Hospital Universitari de Girona Dr. Josep Trueta -ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7

  3. Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study

    Thrombosis Research, Vol. 228, pp. 1-9

2020

  1. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 56, Núm. 9, pp. 551-558

2019

  1. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Predictors of active cancer thromboembolic outcomes: RIETE experience of the Khorana score in cancer-associated thrombosis

    Thrombosis and Haemostasis, Vol. 117, Núm. 6, pp. 1192-1198

2015

  1. Fondaparinux in the initial and long-term treatment of venous thromboembolism

    Thrombosis Research, Vol. 135, Núm. 2, pp. 311-317

2008

  1. Resistant pneumococcal pneumonia

    Infectious Diseases in Clinical Practice, Vol. 16, Núm. 6, pp. 368-375

2006

  1. Clinical syndromes and clinical outcome in patients with pulmonary embolism: Findings from the RIETE registry

    Chest, Vol. 130, Núm. 6, pp. 1817-1822

2001

  1. Guidelines for diagnosing and treating respiratory involvement in cystic fibrosis

    Archivos de Bronconeumologia, Vol. 37, Núm. 8, pp. 316-324

  2. Nebulized antibiotics patients with cystic fibrosis

    Medicina Clinica